Delivery Order SPE2DB22D7065-SPE2DB25FH2DH

Award Date 3/19/25
Potential Completion Date 3/20/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,320.34 delivery order contract is a Firm Fixed Price (FFP) agreement to provide ENTECAVIR 0.5 MG TABLET 30S for the government. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order with a firm fixed price valued at $2,244.95, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENTECAVIR 0.5 MG TABLET 30S, with a completion date of August 6, 2024. There was no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Entecavir 0.5 mg tablets to the Defense Logistics Agency (DLA). The $4,819.44 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of October 17, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award, valued at $2,099.05, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of ENTECAVIR 0.5 MG TABLET 30S, a pharmaceutical product, with a performance period ending on March 26, 2025. This award is a Delivery Order contract with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,624.15 fixed-price delivery order is for ENTECAVIR 0.5MG 30S, a medication, with a performance period through August 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,933.51, is for the delivery of 30-count tablets of the medication Entecavir 0.5 mg. The contract has a firm fixed price pricing type and an ultimate completion date of March 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,758.86 Firm Fixed Price Delivery Order is for the supply of 4564950562 - Entecavir 0.5 mg Tablet 30s, with a period of performance through June 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order with a Firm Fixed Price valued at $5,709.07. The award, placed by the Defense Logistics Agency (DLA), is for the supply of ENTECAVIR 0.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025 and was awarded on March 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $10,436.04 firm-fixed-price delivery order is for the supply of Entecavir 0.5 mg tablets in 30-count packages. The contract has an ultimate completion date of October 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Entecavir 0.5mg tablets. The contract, valued at $7,808.22, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of August 18, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and...
  • SPE2DB22D7065
    Indefinite Delivery Contract
  • SPE2DB22D7065-SPE2DB25FH2DH
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a Delivery Order valued at $1,611.54 for the supply of 4567622089 - ENTECAVIR 0.5 MG TABLET 30S. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation.

Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical that runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/18/25, 11:23 AM